Abstract
Background Identification of reliable, affordable, and easy-to-use strategies for detection of dementia are sorely needed. Digital technologies, such as individual voice recordings, offer an attractive modality to assess cognition but methods that could automatically analyze such data are not readily available.
Methods and findings We used 1264 digital voice recordings of neuropsychological examinations administered to participants from the Framingham Heart Study (FHS), a community-based longitudinal observational study. The recordings were 73 minutes in duration, on average, and contained at least two speakers (participant and clinician). Of the total voice recordings, 483 were of participants with normal cognition (NC), 451 recordings were of participants with mild cognitive impairment (MCI), and 330 were of participants with dementia (DE). We developed two deep learning models (a two-level long short-term memory (LSTM) network and a convolutional neural network (CNN)), which used the raw audio recordings to classify if the recording included a participant with only NC or only DE and to differentiate between recordings corresponding to those that were non-demented (NDE (NC+MCI)) and DE. Based on 5-fold cross-validation, the LSTM model achieved a mean (±std) area under the receiver operating characteristic curve (AUC) of 0.740±0.017, mean balanced accuracy of 0.647±0.027, and mean weighted F1-score of 0.596±0.047 in predicting cases with DE from those with NC. The CNN model achieved a mean AUC of 0.805±0.027, mean balanced accuracy of 0.743±0.015, and mean weighted F1-score of 0.742±0.033 in predicting cases with DE from those with NC. For the task related to classification of participants with DE from NDE, the LSTM model achieved a mean AUC of 0.734±0.014, mean balanced accuracy of 0.675±0.013, and mean weighted F1-score of 0.671±0.015. The CNN model achieved a mean AUC of 0.746±0.021, mean balanced accuracy of 0.652±0.020, and mean weighted F1-score of 0.635±0.031 in predicting cases with DE from those who were NDE.
Conclusion This proof-of-concept study demonstrates the potential that raw audio recordings of neuropsychological testing performed on individuals recruited within a community cohort setting can facilitate dementia screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported in part by the Karen Toffler Charitable Trust, National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through BU-CTSI Grant (1UL1TR001430), a Scientist Development Grant (17SDG33670323) and a Strategically Focused Research Network (SFRN) Center Grant (20SFRN35460031) from the American Heart Association, and a Hariri Research Award from the Hariri Institute for Computing and Computational Science & Engineering at Boston University, Framingham Heart Study National Heart, Lung and Blood Institute contract (N01-HC-25195, HHSN268201500001I) and NIH grants (R01-AG062109, R21-CA253498, R01-AG008122, R01-AG016495, R01-AG033040, R01-AG054156, R01-AG049810, U19 AG068753). Additional support was provided by Boston University Affinity Research Collaboratives program, Boston University Alzheimers Disease Center (P30-AG013846), the National Science Foundation under grants DMS-1664644, CNS-1645681, and IIS-1914792, the Office of Naval Research under grant N00014-19-1-2571, and the NIH under grant R01-GM135930.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Boston University Institutional Review Board. We also obtained consent from all the subjects to perform our research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Revised manuscript with additional results.
Data Availability
All results, code and documentation will be made available on GitHub (https://github.com/vkola-lab/azrt2021) upon manuscript publication. Data in this study cannot be shared publicly due to regulations of local ethical committees. Data might be made available to researchers who meet the criteria (to be provided once all data are available) for access to confidential data and upon IRB approval.
